Thiazolidin-4-one-based compounds interfere with the eicosanoid biosynthesis pathways by mPGES-1/sEH/5-LO multi-target inhibition

No abstract is available for this paper.

• Publication year

  2022

• Venue

  European Journal of Medicinal Chemistry Reports

• Publication date

  2022-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ejmcr.2022.100046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative

  2021cited by this paper
• A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4‐Thiazolidinedione‐Based Molecules as New Dual mPGES‐1/5‐LO Inhibitors

  2020cited by this paper
• Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2 Levels.

  2020cited by this paper
• Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis

  2019cited by this paper
• A review on mPGES-1 inhibitors: From preclinical studies to clinical applications.

  2019cited by this paper
• Discovery of 3-hydroxy-3-pyrrolin-2-one-based mPGES-1 inhibitors using a multi-step virtual screening protocol.

  2018cited by this paper
• Evolution of green chemistry and its multidimensional impacts: A review

  2018cited by this paper
• Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis.

  2018cited by this paper
• Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase

  2017cited by this paper
• Selective upregulation of TNF&agr; expression in classically‐activated human monocyte‐derived macrophages (M1) through pharmacological interference with V‐ATPase

  2017cited by this paper
• Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening.

  2017cited by this paper
• Phosphatase activity of soluble epoxide hydrolase.

  2017cited by this paper
• Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer

  2016cited by this paper
• Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

  2016cited by this paper
• Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.

  2016cited by this paper
• Efficient approach to thiazolidinones via a one-pot three-component reaction involving 2-amino-1-phenylethanone hydrochloride, aldehyde and mercaptoacetic acid

  2016cited by this paper
• Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.

  2016cited by this paper
• Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors.

  2016cited by this paper
• Roles of resolvins in the resolution of acute inflammation

  2015cited by this paper
• Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.

  2015cited by this paper
• Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).

  2014cited by this paper
• Crystallizing Membrane Proteins in the Lipidic Mesophase. Experience with Human Prostaglandin E2 Synthase 1 and an Evolving Strategy

  2014cited by this paper
• Crystal structure of microsomal prostaglandin E2 synthase provides insight into diversity in the MAPEG superfamily

  2013cited by this paper
• Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

  2012cited by this paper
• 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia.

  2011cited by this paper
• Multicomponent reaction design in the quest for molecular complexity and diversity.

  2011cited by this paper
• Three component one-pot synthesis of novel pyrimidino thiazolidin-4-ones catalyzed by activated fly ash

  2009cited by this paper
• Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1

  2008cited by this paper
• Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion.

  2008cited by this paper
• Human soluble epoxide hydrolase: Structural basis of inhibition by 4‐(3‐cyclohexylureido)‐carboxylic acids

  2006cited by this paper
• 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents.

  2005cited by this paper
• Thiazolidin-4-one formation. Mechanistic and synthetic aspects of the reaction of imines and mercaptoacetic acid under microwave and conventional heating.

  2004cited by this paper
• Reaction mechanism of soluble epoxide hydrolase: insights from molecular dynamics simulations.

  2002cited by this paper
• Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

  2002cited by this paper
• Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase.

  1999cited by this paper
• Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels.

  1988cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

  1968cited by this paper
• The preparation of 4-thiazolidones by the reaction of thioglycolic acid with Schiff bases.

  1947cited by this paper

• Targeted metabolomics reveals that phosphorylated Cyclocarya paliurus polysaccharides prevent dextran sulfate sodium-induced ulcerative colitis via modulating eicosanoid metabolism

  2026cites this paper
• Strategies for the multicomponent reaction facilitating the expedited synthesis of functionalized thiazolidinone scaffolds

  2025cites this paper
• Furazanopyrazine-based novel promising anticancer agents interfering with the eicosanoid biosynthesis pathways by dual mPGES-1 and sEH inhibition.

  2025cites this paper
• Essential Oils of Laurus nobilis L.: From Chemical Analysis to In Silico Investigation of Anti-Inflammatory Activity by Soluble Epoxide Hydrolase (sEH) Inhibition

  2024cites this paper
• Antitumor Mechanisms of Lycium barbarum Fruit: An Overview of In Vitro and In Vivo Potential

  2024cites this paper
• New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors

  2024cites this paper
• In silico investigation of novel 5-benzylidene-2- (arylsulfonylhydrazono)thiazolidine-4-ones as potential inhibitors of mPGES-1 and COX-2.

  2023cites this paper
• Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation

  2022cites this paper